Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.60 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.60 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.60 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.60 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.60 |
| ▸ | LCK | P06239 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 3/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | RAB9A | P51151 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | MAOA | P21397 | 1/20 | 0.58 |
| ▸ | GSK3B | P49841 | 2/20 | 0.57 |
| ▸ | BACE1 | P56817 | 2/20 | 0.57 |
| ▸ | BCHE | P06276 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1480744 | 0.95 | LMNA (0.55) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL2516876 | 0.92 | APP (0.58) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL6388039 | 0.90 | APP (0.54) | LCKMAOBRAB9ASMN1; SMN2BCHE | |
| SCHEMBL13242652 | 0.90 | APP (0.54) | LCKMAOBRAB9ASMN1; SMN2BCHE | |
| SCHEMBL12459750 | 0.90 | GSTP1 (0.58) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL21244014 | 0.87 | TSHR (0.47) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL261149 | 0.85 | MEN1 (0.50) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL14732711 | 0.85 | LCK (0.46) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL6584011 | 0.85 | LMNA (0.56) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL31453872 | 0.85 | APP (0.48) | LCKRAB9ASMN1; SMN2ALDH1A1CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3532898-B1 | METHOD FOR PRODUCING A POLYMER BY NITROXYL-CONTROLLED POLYMERISATION, AND POLYMER | FRAUNHOFER GES FORSCHUNG (DE) | 2024-07-31 | — | — | EP | claimed |
| US-11292859-B2 | Method for producing a polymer by nitroxyl-controlled polymerisation, and polymer | FRAUNHOFER-GESELLSCHAFT ZURFÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2022-04-05 | — | — | US | claimed |
| CN-113061203-B | Catalyst and preparation method thereof, and preparation method of styrene monomer isotactic polymer | 中国科学院长春应用化学研究所 | 2022-03-29 | — | — | CN | claimed |
| CN-113061203-A | Catalyst and preparation method thereof, and preparation method of styrene monomer isotactic polymer | 中国科学院长春应用化学研究所 | 2021-07-02 | — | — | CN | claimed |
| US-20190248927-A1 | METHOD FOR PRODUCING A POLYMER BY NITROXYL-CONTROLLED POLYMERISATION, AND POLYMER | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V. (DE) | 2019-08-15 | — | — | US | claimed |
| CN-103709030-A | Environmentally-friendly preparation method of ciprofibrate | ANHUI ANTENG PHARMACEUTICAL CO LTD | 2014-04-09 | — | — | CN | claimed |
| US-7141355-B2 | Radiation-sensitive resin composition | JSR CORPORATION (JP) | 2006-11-28 | — | — | US | claimed |
| EP-1257265-B1 | USE OF 2-PHENYLENE DIAMINE DERIVATIVES FOR THE TREATMENT OF INFECTIONS | BIOAGENCY AG (DE) | 2004-01-21 | — | — | EP | claimed |
| US-20030036532-A1 | Use of 2-phenylene diamine derivatives for the treatment of infections | JOMAA PHARMAKA GMBH (DE) | 2003-02-20 | — | — | US | claimed |
| EP-1257265-A2 | USE OF 2-PHENYLENE DIAMINE DERIVATIVES FOR THE TREATMENT OF INFECTIONS | Jomaa Pharmaka GmbH (DE) | 2002-11-20 | — | — | EP | claimed |
| WO-2001070026-A2 | 2-PHENYLENEDIAMINE DERIVATIVES AS HERBICIDES | JOMAA PHARMAKA GMBH (DE) | 2001-09-27 | — | — | WO | claimed |
| WO-2001062709-A2 | USE OF 2-PHENYLENE DIAMINE DERIVATIVES FOR THE TREATMENT OF INFECTIONS | JOMAA PHARMAKA GMBH (DE) | 2001-08-30 | — | — | WO | claimed |
| EP-1068176-A1 | CYSTEINE AMIDES AS FARNESYL TRANSFERASE INHIBITORS | Jomaa, Hassan (DE) | 2001-01-17 | — | — | EP | claimed |
| WO-2000027803-A1 | CYSTEINE AMIDES AS FARNESYL TRANSFERASE INHIBITORS | JOMAA, HASSAN (DE) | 2000-05-18 | — | — | WO | claimed |
| CN-120025475-A | Polymer and deprotection system, method and application | 上海微悦芯材新材料有限责任公司 | 2025-05-23 | — | — | CN | disclosed |
| WO-2025095132-A1 | POROUS RESIN BEAD, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING NUCLEIC ACID USING SAID POROUS RESIN BEAD | 日東電工株式会社 | 2025-05-08 | — | — | WO | disclosed |
| EP-3532898-B1 | METHOD FOR PRODUCING A POLYMER BY NITROXYL-CONTROLLED POLYMERISATION, AND POLYMER | FRAUNHOFER GES FORSCHUNG (DE) | 2024-07-31 | — | — | EP | disclosed |
| EP-0304613-B1 | BENZOPYRAN DERIVATIVES | BASF Aktiengesellschaft (DE) | 1991-06-26 | — | — | EP | disclosed |
| US-4958021-A | PRESSURE AND HEAT SENSITIVE RECORDING MATERIALS | BASF AKTIENGESELLSCHAFT (DE) | 1990-09-18 | — | — | US | disclosed |
| EP-0304613-A1 | Benzopyran derivatives | BASF Aktiengesellschaft (DE) | 1989-03-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030036532-A1 | Use of 2-phenylene diamine derivatives for the treatment of infections | HRH2, ASPH, NQO2 | LMNA 3574/4885CYP1A2 91/4885PTGS1 1766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.